WW
Wish Wang
Group Chairman
Leads long-term strategy, European partnerships and governance systems.
Shuaizhijia Group
A European-backed healthcare industry partner
Shuaizhijia Group is a foreign-invested enterprise focused on the pharmaceutical industry, serving B2B clients, investors and consumers with professionalism, compliance and trust.
2018
China business center established in Beijing
2020
European partnership and regulatory affairs team formed
2022
Commercial network expanded across eastern and southern China
2025
Digital pharmaceutical collaboration platform initiated
Shuaizhijia Group
Compliance and Quality Boundaries
Premium pharmaceutical cooperation is built on disciplined, transparent and traceable ways of working.
01Project Review
02Documentation
03Quality Tracking
Compliance is the operating baseline, supported by project review, supplier qualification, documentation and quality tracking.
Cross-border projects use bilingual collaboration, milestone reviews and risk planning to reduce uncertainty.
We protect long-term trust by avoiding unverified clinical, regulatory or commercial claims.
Shuaizhijia Group
Leadership
WC
Wenjuan Chen
China General Manager
Oversees local commercialization, operations and key partner delivery.
KC
Kevin Chen
Regulatory & Compliance Lead
Coordinates regulatory tracking, documentation, quality collaboration and risk review.
Shuaizhijia Group
Culture
A shared operating compass aligning global resources, local execution and long-term trust.
01
Mission
02
Vision
03
Values
Mission
Make trusted healthcare resources serve China more efficiently.
Vision
Become a long-term bridge between global healthcare and local demand.
Values
Professionalism, transparency, responsibility and collaboration.